Early Access Provision for Innovative Medicinal Products in Oncology: Challenges and Opportunities by Andriy Krendyukov

Get full text

Early access provision: Awareness, educational needs and opportunities to improve oncology patients’ access to care by Andriy Krendyukov, Sanjay Singhvi, Yianick Green-Morrison, Markus Zabransky

Get full text

Development and 10-year history of a biosimilar: the example of Binocrit by Matti Aapro, Andriy Krendyukov, Nadja Höbel, Andreas Seidl, Pere Gascón

Get full text

Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rati... by Bernardo Leon Rapoport, Matti Aapro, Marianne Paesmans, Ronwyn van Eeden, Teresa Smit, Andriy Krendyukov, Jean Klastersky

Get full text

Efficacy and safety of asunercept, a CD95L-selective inhibitor, in hospitalised patients with moderate-to-severe COVID-19: ASUNCTIS, a multicentre, randomised, open-label, controll... by Maria Pilar Ruiz Seco, José Ramón Paño Pardo, Christian Schoergenhofer, Christiane Dings, Thorsten Lehr, Felix Herth, Andriy Krendyukov, Carola Straub, Martin Kappler, Bernd Jilma, Harald Fricke, Julian Pardo, Diego de Miguel, Meinolf Thiemann, Michael Bergmann, Henning Walczak, Thomas Hoeger

Get full text